MGMT and glioblastoma: In glioblastoma, oncogenic mutations in key signaling networks, such as p53 and retinoblastoma signaling, as well as methylation of the O6-methylguanine-DNA methyltransferase (MGMT) promoter, are frequently associated with DNA repair pathway alterations [38,39].